FDA Grants EUA for Novavax’s COVID Vaccine
Opinion | On July 13, 2022, the U.S. Food and Drug Administration (FDA) granted Emergency Use Authorization (EUA) to Novavax to distribute its experimental two-dose NVX-CoV2373 (also known as “Nuvaxovid” and “Covovax”) COVID-19 vaccine for use by adults. The decision was expected, given the favorable recommendation by the FDA’s Vaccines and Related Biological Products Advisory […]
Baby Formula Industry Slammed for Manipulative Social Media Marketing
In 1981, the World Health Assembly released a public health strategy known as The International Code of Marketing of Breast-Milk Substitutes to protect breastfeeding and “stop the aggressive and inappropriate marketing of breast-milk substitutes.”1 This initiative came after years of unethical formula marketing specifically to mothers in low-income parts of the world, which led to “dramatic […]
‘COVID-19 Rebound’ May Be Worse Than Initial COVID Illness
On May 24, 2022, the U.S. Centers for Disease Control and Prevention (CDC) issued a health advisory to health care providers, public health departments and the general public regarding Pfizer’s antiviral drug Paxlovid, designed to treat symptoms of COVID-19. The advisory warns that some people who take Paxlovid may experience a recurrence of COVID symptoms […]
Claims for Injury, Death from COVID Shots Surge
Opinion | The Countermeasures Injury Compensation Program (CICP) is a program of the U.S. government that provide financial compensation for people who have suffered serious injuries or death from vaccines, biologics, antivirals or other drugs, as well medical devices used to “diagnose, prevent or treat a declared pandemic, epidemic or security threat.” The program was […]
U.S. Becomes First Country to Give mRNA COVID Vaccine to Babies
On June 15, 2022 the Vaccines and Related Biological Products Advisory Committee (VRBPAC) of the U.S. Food and Drug Administration (FDA) unanimously advised the FDA staff to grant Moderna and Pfizer/BioNTech an Emergency Use Authorization (EUA) amendment to allow their mRNA COVID vaccines to be given to children under age five and as young as […]
CDC Distributing Monkeypox Vaccines Nationwide While Raising Monkeypox Travel Alert to Level 2
On June 6, 2022, the U.S. Centers for Disease Control and Prevention (CDC) raised its monkeypox travel alert to Level 2, warning Americans to “Practice Enhanced Precautions.”1 The agency stated that monkeypox cases have been rising in at least 29 countries, with 1,019 infections reported to date. Currently, the United States has confirmed 31 cases […]
